Knowledge survey to assess the effectiveness of educational materials among healthcare professionals who prescribe Lemtrada® (alemtuzumab)

Study type

• Study topic:
  Human medicinal product
• Study type:
  Non-interventional study
• Scope of the study:
  Effectiveness study (incl. comparative)
• Data collection methods:
  Primary data collection

Non-interventional study

• Non-interventional study design:
  Cross-sectional

Study drug and medical condition

• Name of medicine:
  LEMTRADA

Population studied

• Short description of the study population:
  Healthcare Professional (HCPs) involved in the treatment of MS using Lemtrada.; Inclusion criteria; • HCP is a neurologist/MS specialist; • HCP has prescribed Lemtrada to at least one patient within the past 6 months; • HCP supplies informed consent by ticking a box on the survey website.; Exclusion criteria; • HCP has not prescribed Lemtrada within the past 6 months; • Participation in the questionnaire in Wave 1.
• Age groups:
  Adults (18 to < 46 years)

  Adults (46 to < 65 years)

  Adults (65 to < 75 years)

  Adults (75 to < 85 years)

  Adults (85 years and over)
• Estimated number of subjects:
  0

Study design details

• Main study objective:
  The overall objective of the survey is to assess descriptively the knowledge level of Healthcare Professionals (HCPs) with regard to educational messages and thus the effectiveness of the educational materials to support the safe use of LEMTRADA.
• Outcomes:
  Awareness of HCP and patient educational materials, knowledge of the key points of the educational materials. Subgroup comparisons based on country and specialist role.
• Data analysis plan:
  Descriptive statistics including HCP understanding and awareness of educational materials at 18 and 36 months after the launch of Lemtrada.